Investigational Drug Information for Marimastat
✉ Email this page to a colleague
What is the drug development status for Marimastat?
Marimastat is an investigational drug.
There have been 4 clinical trials for Marimastat.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 31st 1997.
The most common disease conditions in clinical trials are Lung Neoplasms, Small Cell Lung Carcinoma, and Breast Neoplasms. The leading clinical trial sponsors are Boston Children’s Hospital, ILEX Oncology Services, Incorporated, and National Cancer Institute (NCI).
Summary for Marimastat
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 5,049 |
WIPO Patent Applications | 0 |
Japanese Patent Applications | 1,913 |
Clinical Trial Progress | Phase 3 (1997-01-31) |
Vendors | 69 |
Recent Clinical Trials for Marimastat
Title | Sponsor | Phase |
---|---|---|
Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options. | Boston Children's Hospital | Phase 1 |
Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options. | Boston Children’s Hospital | Phase 1 |
Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy | National Cancer Institute (NCI) | Phase 3 |
Clinical Trial Summary for Marimastat
Top disease conditions for Marimastat
Top clinical trial sponsors for Marimastat
US Patents for Marimastat
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |